Griesheim, Germany

Hans-Peter Buchstaller

USPTO Granted Patents = 51 

 

 

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 142(Granted Patents)

Forward Citations (Not Self Cited) = 136(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Sulzbach/Ts., DE (1997)
  • Weiterstadt, DE (2002 - 2013)
  • Griesheim, DE (2008 - 2023)

Company Filing History:


Years Active: 1997-2023

Loading Chart...
Loading Chart...
Loading Chart...
51 patents (USPTO):Explore Patents

Title: Innovations in Pharmaceuticals: The Patents of Hans-Peter Buchstaller

Introduction

Hans-Peter Buchstaller, a distinguished inventor based in Griesheim, Germany, has made significant contributions to the field of pharmaceuticals, holding an impressive total of 51 patents. His work primarily focuses on developing compounds that can have a substantial impact on treating critical diseases, including cancer.

Latest Patents

Among his latest innovations are patents for thiophene derivatives and bicyclic heterocyclic derivatives. These compounds, formulated under specific chemical structures, serve as inhibitors of pyruvate dehydrogenase kinase (PDHK). This innovative approach can potentially revolutionize the treatment strategies for various diseases, emphasizing the critical role of his research in modern medicine.

Career Highlights

Buchstaller's career is marked by his tenure with reputable organizations like Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His expertise in patentable innovations within these leading pharmaceutical companies has enabled the development of advanced therapeutic solutions, reflecting his commitment to enhancing patient care through scientific discovery.

Collaborations

Throughout his career, Buchstaller has collaborated with notable professionals such as Christian Sirrenberg and Dieter Dorsch. These partnerships have fostered a dynamic exchange of ideas and research, contributing significantly to the success of his innovative projects.

Conclusion

Hans-Peter Buchstaller exemplifies the essence of invention and innovation in the pharmaceutical industry. His tireless work on compounds aimed at treating complex diseases demonstrates his dedication to improving lives through advanced scientific research. As he continues to lead projects at the forefront of medicine, his patents will undoubtedly influence the landscape of pharmaceutical treatments for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…